US SB4232 | 2023-2024 | 118th Congress
Status
Spectrum: Partisan Bill (Republican 1-0)
Status: Introduced on May 1 2024 - 25% progression
Action: 2024-05-01 - Read twice and referred to the Committee on the Judiciary.
Pending: Senate Judiciary Committee
Text: Latest bill text (Introduced) [PDF]
Status: Introduced on May 1 2024 - 25% progression
Action: 2024-05-01 - Read twice and referred to the Committee on the Judiciary.
Pending: Senate Judiciary Committee
Text: Latest bill text (Introduced) [PDF]
Summary
A bill to amend title 18, United States Code, to prohibit former employees of covered health agencies from serving on the board of entities involved in development and research of a drug, biological product, or device and from profiting from a drug, biological product, or device, and for other purposes.
Title
FAUCI Act Fixing Administrations Unethical Corrupt Influence Act
Sponsors
Sen. J.D. Vance [R-OH] |
History
Date | Chamber | Action |
---|---|---|
2024-05-01 | Senate | Read twice and referred to the Committee on the Judiciary. |
Same As/Similar To
HB8211 (Same As) 2024-05-01 - Referred to the House Committee on the Judiciary.
Subjects
US Congress State Sources
Type | Source |
---|---|
Summary | https://www.congress.gov/bill/118th-congress/senate-bill/4232/all-info |
Text | https://www.congress.gov/118/bills/s4232/BILLS-118s4232is.pdf |